N. Barry Elkind

1.1k citations
14 papers · 910 indexed · h-index 13
Topics
Drug Transport and Resistance Mechanisms (6 papers)Cancer-related Molecular Pathways (4 papers)Trace Elements in Health (3 papers)

In The Last Decade

N. Barry Elkind

14 papers receiving 881 citations

Peers

N. Barry Elkind
Comparison fields: 5 of 70
  • Molecular Biology 572
  • Oncology 571
  • Surgery 139
  • Cell Biology 129
  • Pulmonary and Respiratory Medicine 81
Replace Akiko Tohgo with:
Akiko Tohgo Japan
Claudia L. Flemming Australia
Svein A. Carlsen Canada
Annemarie Larkin Ireland
Do-Sun Byun United States
DW Kufe United States
Cynthia Kosinski United States
Zhijie Xiao China
Nicholas Davies United Kingdom
Daniel Triner United States
N. Barry Elkind relative to Akiko Tohgo Japan Akiko Tohgo's profile →
Citations per field
00.5×3.6×
Akiko Tohgo · 1×
Citations per year

Countries citing papers authored by N. Barry Elkind

Since Specialization
Citations

This map shows the geographic impact of N. Barry Elkind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Barry Elkind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Barry Elkind more than expected).

Fields of papers citing papers by N. Barry Elkind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Barry Elkind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Barry Elkind. The network helps show where N. Barry Elkind may publish in the future.

Co-authorship network of co-authors of N. Barry Elkind

This figure shows the co-authorship network connecting the top 25 collaborators of N. Barry Elkind. A scholar is included among the top collaborators of N. Barry Elkind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Barry Elkind. N. Barry Elkind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 31
2 30
3 30
4 126
5 195
6 85
7 15
8 94
9 42
10 24
11
The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.
18
12
Spot-1, a novel NLS-binding protein that interacts with p53 through a domain encoded by p(CA)n repeats.
9
13
Does wild-type p53 play a role in normal cell differentiation?
49
14
c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
162

About N. Barry Elkind

N. Barry Elkind is a scholar working on Oncology, Nutrition and Dietetics and Molecular Biology, having authored 14 papers that have together received 910 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Cancer-related Molecular Pathways (4 papers) and Trace Elements in Health (3 papers). The work is most often cited by research in Oncology (571 citations), Molecular Biology (572 citations) and Cell Biology (129 citations). N. Barry Elkind has collaborated with scholars based in Hungary, Israel and United States. Frequent co-authors include Csilla Özvegy‐Laczka, Varda Rotter, Judit Cserepes, Balázs Sarkadi, David Reisman, László Homolya, B Roy, Peter Novick, Zsófia Szentpétery and András Váradi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026